ALZN icon

Alzamend Neuro (ALZN)

NASDAQ

(

NaN%

)

1D
5D
1M
6M
1Y
5Y
Market open

ALZN: / ₿ NaN BTC / NaN Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$1.58 - $10.17
$7.41M
1.15
3.80M
-
No

What is Alzamend Neuro (ALZN)?

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

The Alzamend Neuro (ALZN) stock price has been falling

The Alzamend Neuro, Inc. Common Stock (ALZN) stock price today is , reflecting a NaN% move since the market opened. The company’s market capitalization stands at $7.41M, with a daily trading volume of shares. The previous closing price was .

Get started with Alzamend Neuro (ALZN)

Ready to get started? Follow the steps below, or read our guide on how to buy Alzamend Neuro stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy ALZN

Search for ALZN in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy ALZN.

ALZN FAQs

ALZN is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

ALZN is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Alzamend Neuro, Inc. Common Stock (ALZN) has traded between a low of $1.58 and a high of $10.17.

ALZN is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Alzamend Neuro? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
ALZN icon
ALZN

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Alzamend Neuro in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

TPET icon
ONDS icon

ONDS

STAK icon

STAK

NVDA icon

NVDA

Top gainers

Browse today’s biggest stock market winners

OTRKQ icon

OTRKQ

PPBT icon
ZCMD icon

ZCMD

BURU icon

BURU

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

ILLRW icon
OUSTZ icon

OUSTZ

GOEVQ icon

GOEVQ

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.